# Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks

> **NCT02679092** · NA · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- Legally Induced Abortion Without Mention of Complication

## Interventions

- **DRUG:** Misoprostol
- **DRUG:** Mifepristone
- **DEVICE:** Hygroscopic cervical dilators

## Key facts

- **NCT ID:** NCT02679092
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2020-02
- **Final completion:** 2020-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding changes.
- **Last updated:** 2019-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02679092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02679092, "Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02679092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*